Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin and Neostigmine/Atropine for Prevention of PDPH After Cesarean Section
NCT07916116Phase 3Recruiting
- Sponsor
- Assiut University
- Start
- Mar 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 3 trial of gabapentin, neostigmine, atropine in post-dural puncture headache (PDPH), sponsored by Assiut University. Started Mar 2026; status: recruiting.
02
Drugs
gabapentinneostigmineatropine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT07916116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07916116.